UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

Nature reviews. Drug discovery, 2007-02, Vol.6 (2), p.140-148

2007

Volltextzugriff (PDF)

A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

Clinical pharmacokinetics, 2014-07, Vol.53 (7), p.625-636

2014

Volltextzugriff (PDF)

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

Clinical pharmacokinetics, 2006-01, Vol.45 (9), p.931-956

2006

Volltextzugriff (PDF)

Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults

Biopharmaceutics & drug disposition, 2015-05, Vol.36 (4), p.245-257

2015

Volltextzugriff (PDF)

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

Clinical pharmacokinetics, 2010-03, Vol.49 (3), p.189-206

2010

Volltextzugriff (PDF)

In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism

Drug metabolism and disposition, 2015-11, Vol.43 (11), p.1806-1814

2015

Volltextzugriff (PDF)

Personalized Drug Dosage – Closing the Loop

Pharmaceutical research, 2017-08, Vol.34 (8), p.1539-1543

Tucker, Geoffrey T

2017

Volltextzugriff (PDF)

Assessment of algorithms for predicting drug–drug interactions via inhibition mechanisms: comparison of dynamic and static models

British journal of clinical pharmacology, 2011-01, Vol.71 (1), p.72-87

2011

Volltextzugriff (PDF)

Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling

Clinical pharmacokinetics, 2013-12, Vol.52 (12), p.1085-1100

2013

Volltextzugriff (PDF)

Erratum to: A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

Clinical pharmacokinetics, 2015-06, Vol.54 (6), p.671-671

2015

Volltextzugriff (PDF)

Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

British journal of clinical pharmacology, 2018-07, Vol.84 (7), p.1620-1621

2018

Volltextzugriff (PDF)

Letter to the editor about reporting drug concentrations and pharmacokinetics in regional anesthesia and pain medicine

Regional anesthesia and pain medicine, 2024-02, Vol.49 (2), p.151-151

2024

Volltextzugriff (PDF)

When Regional Anesthesia Met Pharmacokinetics

Anesthesiology (Philadelphia), 2022-04, Vol.136 (4), p.588-593

2022

Volltextzugriff (PDF)

Metformin disposition—A 40‐year‐old mystery

British journal of clinical pharmacology, 2020-08, Vol.86 (8), p.1452-1453

2020

Volltextzugriff (PDF)

Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia

Biochemical pharmacology, 2017-04, Vol.129, p.85-95

2017

Volltextzugriff (PDF)

Comment on: “The pharmacokinetics of metformin in patients receiving intermittent haemodialysis” by Sinnappah et al

British journal of clinical pharmacology, 2021-08, Vol.87 (8), p.3370-3371

2021

Volltextzugriff (PDF)

The British Journal of Clinical Pharmacology: The first 50 years

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.4-11

2024

Volltextzugriff (PDF)

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA

Journal of psychopharmacology (Oxford), 2006-11, Vol.20 (6), p.842-849

2006

Volltextzugriff (PDF)

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation

British journal of clinical pharmacology, 2018-03, Vol.84 (3), p.462-476

2018

Volltextzugriff (PDF)

A series acceleration algorithm for the gamma-Pareto (type I) convolution and related functions of interest for pharmacokinetics

Journal of pharmacokinetics and pharmacodynamics, 2022-04, Vol.49 (2), p.191-208

2022

Volltextzugriff (PDF)

Physiologically based pharmacokinetic-pharmacodynamic modeling to the rescue: understanding how resuscitation from local anesthetic overdose with lipid emulsions works

Anesthesiology (Philadelphia), 2014-04, Vol.120 (4), p.795-796

Tucker, Geoffrey T

2014

Volltextzugriff (PDF)

Physiologically based mechanistic modelling to predict complex drug–drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut—The effect of diltiazem on the time-course of exposure to triazolam

European journal of pharmaceutical sciences, 2010-03, Vol.39 (5), p.298-309

2010

Volltextzugriff (PDF)

Prediction of intestinal first-pass drug metabolism

Current drug metabolism, 2007-10, Vol.8 (7), p.676-684

2007

Volltextzugriff (PDF)

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions

Current drug metabolism, 2008-06, Vol.9 (5), p.384-393

2008

Volltextzugriff (PDF)

Research priorities in pharmacokinetics

British journal of clinical pharmacology, 2012-06, Vol.73 (6), p.924-926

Tucker, Geoffrey T

2012

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(254)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(180)
Humans
(130)
Pharmacology & Pharmacy
(72)
Male
(64)
Female
(61)
Biological And Medical Sciences
(60)
Adult
(46)
Medical Sciences
(46)
Pharmacology. Drug Treatments
(38)
Animals
(29)
Models, Biological
(28)
Middle Aged
(27)
Pharmacokinetics
(27)
Kinetics
(26)
Adolescent
(23)
Aged
(20)
General Pharmacology
(20)
Physical Sciences
(19)
Pharmaceutical Preparations - Metabolism
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism

Personalized Drug Dosage – Closing the Loop

Assessment of algorithms for predicting drug–drug interactions via inhibition mechanisms: comparison of dynamic and static models

Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling

Erratum to: A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Letter to the editor about reporting drug concentrations and pharmacokinetics in regional anesthesia and pain medicine

When Regional Anesthesia Met Pharmacokinetics

Metformin disposition—A 40‐year‐old mystery

Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia

Comment on: “The pharmacokinetics of metformin in patients receiving intermittent haemodialysis” by Sinnappah et al

The British Journal of Clinical Pharmacology: The first 50 years

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation

A series acceleration algorithm for the gamma-Pareto (type I) convolution and related functions of interest for pharmacokinetics

Physiologically based pharmacokinetic-pharmacodynamic modeling to the rescue: understanding how resuscitation from local anesthetic overdose with lipid emulsions works

Physiologically based mechanistic modelling to predict complex drug–drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut—The effect of diltiazem on the time-course of exposure to triazolam

Prediction of intestinal first-pass drug metabolism

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions

Research priorities in pharmacokinetics

Suchergebnisse filtern